Clinical application of proton beams in the treatment of uveal melanoma: The first therapies carried out in Italy and preliminary results (CATANA project)

Tumori

Volumn 89, Issue 5, 2003, Pages 502-509

  Spatola, Corrado ^a,c   Privitera, Giuseppe ^a   Raffaele, Luigi ^a   Salamone, Vincenzo ^a   Cuttone, Giacomo ^b   Cirrone, Pablo ^b   Sabini, Maria Gabriella ^b   Nigro, Salvatore Lo ^b  

^a UNIVERSITY OF CATANIA   (Italy)

^b INFN SEZIONE DI CATANIA   (Italy)

^c UNIVERSITY OF CATANIA   (Italy)

Author keywords

Hadron therapy; Proton beams; Uveal melanoma

Indexed keywords

ADULT; AGED; APPARATUS; ARTICLE; CANCER CONTROL; CANCER INVASION; CANCER SIZE; CANCER SURVIVAL; CHOROID; CILIARY BODY; CLINICAL ARTICLE; FEMALE; FOLLOW UP; HADRON; HUMAN; IRIS TUMOR; ITALY; MALE; OUTCOMES RESEARCH; PROTON RADIATION; RADIATION DOSE; SURVIVAL RATE; ULTRASOUND; UVEA MELANOMA; VISION;

EID: 0346996605     PISSN: 03008916     EISSN: None     Source Type: Journal    
DOI: 10.1177/030089160308900508     Document Type: Article

References (34)

1. Bonnet DE, Kacperek A, Sheen MA: The 62 MeV proton beam for the treatment of ocular melanoma at Clatterbridge. Br J Radiol, 66: 907-914, 1993.
2. Egger E, Zografos L, Perret C, Gailloud C: Proton beam irradiation of choroidal melanomas at the PSI: Technique and results. In: Radiotherapy of intraocular and orbital tumors, Alberti WE, Sagerman RH (Eds), pp 52-57, Springer-Verlag, Berlin, 1993.
3. Egger E, Zografos L, Munckel G: Results of proton radiotherapy for uveal melanomas. In: Radiotherapy of ocular disease, Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (Eds), vol 30, pp 111-122, Front Radiat Ther Oncol, Karger, Basel, 1997.
4. Egger E, Schalenbourg A, Zografos L, Bercher L, Boehringer T, Chamot L, Goitein G: Maximizing local tumor control and survival after proton beam radiotherapy of uveal melanoma. Int J Radiat Oncol Biol Phys, 51: 138-147, 2001.
5. Egger E, Zografos L, Schalenbourg A, Beati D, Boehringer T, Chamot L, Goitein G: Eye retention after proton beam radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys, 55: 867-880, 2003.
6. McLean W, Gamel JW: Uveal (intraocular) melanoma. Cancer J, 9 (number 1), 1996.
7. Bosworth JL, Packer S, Rotman M: Choroidal melanoma: 1251 plaque therapy. Radiology, 169: 249-251, 1988.
8. Augsburger JJ, Correa ZM, Freire J: Long-term survival in choroidal and ciliary body melanoma after enucleation versus plaque radiation therapy. Ophthalmology, 105: 1670-1678, 1998.
9. Augsburger JJ, Schneider S, Freire J: Survival following enucleation versus plaque radiotherapy in statistically matched subgroups of patients with choroidal melanomas: results in patient treated between 1980-1987. Graefe's Arch Clin Exp Ophthalmol, 237: 558-567, 1999.
10. Lommatzsch PK, Werschnick C, Schuster E: Long-term follow up of Ru106-Rh106 brachytherapy for posterior uveal melanoma. Graefe's Arch Clin Exp Ophthalmol, 238: 129-137, 2000.
11. Petrovich Z, Luxton G, Langholz B: Episcleral plaque radiotherapy in the treatment of uveal melanomas: Int J Radiat Oncol Biol Phys, 24: 247-251, 1992.
12. Wison MW, Hungerford JL: Comparison of episcleral plaque and proton beam radiation therapy for the treatment of choroidal melanoma: Ophthalmology, 106: 1579-1587, 1999.
13. Seddon JM, Gragoudas ES, Egan KM: Relative survival rates after alternative therapies for uveal melanoma. Ophthalmology, 97: 769-777, 1990.
14. Tokuuye K, Akine Y, Sumi M: Fractionated stereotactic radiotherapy for choroidal melanoma. Radiother Oncol, 43: 87-91, 1997.
15. Brockhurst RJ: Tantalum buttons for localization of malignant melanoma in proton therapy. Ophthalmic Surg, 11: 352-353, 1980.
16. Goiten M, Miller T: Planning proton therapy of the eye. Med Phys, 10: 275-283, 1983.
17. Sheen M: EYEPLAN proton therapy planning program. Clatterbridge Centre for Oncology, Internal report, 1987.
18. Cantrill HL, Cameron JD, Ramsay RC, Knobloch WH: Retinal vascular changes in malignant melanoma of the choroid. Am J Ophthalmol, 97: 411-418, 1984.
19. Castro JR, Char DH, Petti PL: 15 years experience with helium ion radiotherapy for uveal melanoma. Int J Radiat Oncol Biol Phys, 39: 989-996, 1997.
20. Char DH, Kroll SM, Quivey J, Castro J: Long term visual outcome of radiated uveal melanomas in eyes eligible for randomization to enucleation versus brachytherapy. Br J Ophthalmol, 80: 117-124, 1996.
21. Char DH, Kroll SM, Castro J: Long-term follow up after uveal melanoma charged particle therapy. Trans Am Ophthalmol Soc, 95: 171-187, 1997.
22. Char DH, Kroll SM, Castro J: Ten-year follow-up of helium ion therapy for uveal melanoma. Am J Ophthalmol, 125: 81-89, 1998.
23. Chauvel P, Sauerwein W, Bornfeld N: Clinical and technical requirements for proton treatment planning of ocular disease. In: Radiotherapy of ocular disease, Wiegel T, Bornfeld N, Foerster MH, Hinkelbein W (Eds), vol 30, pp 133-142, Front Radiat Ther Oncol, Karger, Basel, 1997.
24. Courdi A, Caujolle JP, Grange JD: Results of proton therapy of uveal melanomas treated in Nice. Int J Radiat Oncol Biol Phys, 45: 5-11, 1999.
25. Desjardins L, Levy C, d'Hermies F, Frau E, Schlienger P, Habrand J-L, Mammar H, Schwartz L, Mazal A, Delacroix S, Nauraye C, Ferrand R, Asselain B: Initial results of proton therapy in choroidal melanoma at the Orsay Center for proton therapy; the first 464 cases. Cancer Radiother, 1: 222-226, 1997.
26. Finger PT: Radiation therapy for choroidal melanoma. Surv Ophthalmol, 42: 215-232, 1997.
27. Gragoudas ES, Seddon JM, Egan K: Long-term results of proton beam irradiated uveal melanomas. Arch Ophthalmol, 94: 349-353, 1987.
28. Gragoudas ES, Seddon JM, Egan K: Metastases from uveal melanoma after proton beam irradiation. Ophthalmology, 95: 992-999, 1988.
29. Gragoudas ES, Seddon JM, Egan K: Intraocular recurrence of uveal melanoma after proton beam irradiation. Ophthalmology, 99: 760-767, 1992.
30. Gragoudas ES, Lane AM, Regan S: A randomized controlled trial of varying radiation doses in the treatment of choroidal melanoma: Arch Ophihalmol, 118: 773-778, 2000.
31. Munzenrider JE, Gragoudas ES, Seddon JM: Conservative treatment of uveal melanoma: probability of eye retention after proton treatment. Int J Radiat Oncol Biol Phys, 15: 553-558, 1988.
32. Munzenrider JE, Verhey LJ, Gragoudas ES: Conservative treatment of uveal melanoma: local recurrence after proton beam therapy. Int J Radiat Oncol Biol Phys, 17: 493-498, 1989.
33. Munzenrider JE: Proton therapy for uveal melanomas and other eye lesions. Strhlenther Onkol, 175 (Suppl II): 68-73, 1999.
34. Damato BE, Paul J, Foulds WS: Risk factors for residual and recurrent uveal melanoma after trans-scleral local resection. Br J Ophthalmol, 80: 102-108, 1996.